Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Sep 27, 2022 11:48am
100 Views
Post# 34989525

RE:RE:RE:RE:RE:RE:RE:57,000 views, THTX YouTube video link below

RE:RE:RE:RE:RE:RE:RE:57,000 views, THTX YouTube video link belowHigh minded stubborness. But I do have some sympathy for them on this as it is not a pretty place to go. Remember they did make an attempt a while back to engage with Water Tower Research, if I recall correctly the name. They were a retail oriented shop and the whole thing was quite low-end. Like Qwerty after watching ZipTrader, I suspect TH's executives felt they needed a shower after the Water Tower Research thing. But when you have managed you stock price into the $2 range, your makret  cap into the $200 million range and your daily trading volume into the 20,000 range, you likely need to do things  you never imagined you would have to do to get out of that spot. Not illegal things, just things that are clearly beneath your dignity. Hopefully, TH can come out with really good cancer news and that quickly propels the stock to all the places it needs to be to achieve the necessary price, market cap and trading volume goals. If not, they may need to hold their nose and dive into a retail strategy. They likely should have done so a couple of years ago but with phase 1b news likely out soon, they may be able to avoid it now.

Lee430 wrote: We know Thera follows this board and we know they have been contacted directly many times with our concerns/suggestions over their lack of retail engagement, so what could possibly be the reason for ignoring such a crucial and low hanging fruit to get us back into the institutional sand box? Any thoughts?


scarlet1967 wrote: So true also the ugliness could apply to the institutions look at Ed Nash's past roller coaster PTs and as per yourself recent trading by other institutions to make a quick profit. If you want to maximize your profit you need to use all avenues, a flexible multi purpose marketing approach others are doing it for a reason so why THTX almost certainly ignoring that part of the investment community?
SPCEO1 wrote: I really, really doubt TH had anything to do with this. 

TH can get involved in the retail end of the investment sphere without getting involved in something like this. But no matter how you cut it, the retail end of the investment universe, now more than ever, is not pretty.

Despite how ugly that clip w as, the fact this caused the stock price to rise on decent volume is yet another indicator to TH that there is real hope for them to positively influence their share price by pursuing a retail strategy, particulalrly whent heir share price is too low, their market cap too low and their trading volume too low for institutional investors to participate in any meaningful way.

A higher share price always gives a company a better chance at economically building their business. For small biotech companies,it is one of the critical success factors.

qwerty22 wrote:

Either this character just randomly landed on THTX or THTX put themselves in front of him. Honestly the second option seems like the worst.

I don't see how this vid has anything to do with building their business

 

realitycheck4u wrote:

 

-- And what have we learned within this video?. We have learned that filtering out information to the retail channel helps build momentum.

 

SPCEO1 wrote: Just about everything this gentleman says about Trogarzo is embarrassingly wrong.

 

TH1902 wrote: Was curious so I found the video that referenced THTX, here it is, starts around 4:30 point, pitched as a trade on FDA response expected Oct. 3rd

https://www.youtube.com/watch?v=O6tkOY0GTVI

 

 

 

 

 

 




<< Previous
Bullboard Posts
Next >>